211 studies found for:    Open Studies | "Hepatitis B"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention: Drug: Tenofovir/ & Emtricitabine
2 Recruiting Tenofovir DF With or Without Peginterferon for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention: Drug: Peginterferon and Tenofovir
3 Recruiting Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention:
4 Recruiting Observational Study of Persons With Hepatitis B Virus Infection in North America
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention:
5 Unknown  Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Intervention: Drug: Peginterferon alfa-2a
6 Recruiting Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral Load
Condition: Chronic Hepatitis B
Intervention: Drug: Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
7 Recruiting "Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection
Condition: Hepatitis B
Intervention:
8 Recruiting Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System
Condition: Hepatitis B Vaccine
Interventions: Biological: Adjuvanted Hepatitis B surface antigen (HBsAg) candidate vaccine GSK2231392A.;   Biological: EngerixTM-B
9 Recruiting Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Biological: HBV DNA vaccine;   Other: Placebo
10 Unknown  Adolescents' Response to Hepatitis B Vaccine Booster Dose
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
11 Recruiting TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA
Condition: Chronic Hepatitis B
Interventions: Drug: Lamivudine plus adefovir;   Drug: Tenofovir
12 Recruiting Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B
Condition: Hepatitis B
Intervention: Drug: Entecavir and peginterferon
13 Recruiting A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Conditions: Hepatitis B;   HBV
Interventions: Drug: Single Ascending Dose (SAD) Cohorts GS-9620;   Drug: Multiple Ascending Dose (MAD) Cohorts
14 Recruiting HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B
Condition: Hepatitis B
Intervention:
15 Recruiting A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Condition: Hepatitis B
Interventions: Drug: Single Ascending Dose (SAD) Cohorts GS-9620;   Drug: Multiple Ascending Dose (MAD) Cohorts GS-9620
16 Recruiting HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B
Condition: Hepatitis B
Intervention:
17 Recruiting A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)
Condition: HBeAg(+) Chronic Hepatitis B
Interventions: Drug: Clevudine;   Drug: Clevudine + Peg-interferon
18 Unknown  The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma
Conditions: Hepatitis B;   Hepatocellular Carcinoma
Intervention: Procedure: radiofrequency ablation
19 Recruiting Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Condition: Chronic Hepatitis B
Interventions: Drug: tenofovir disoproxil fumarate 300mg per day;   Drug: Placebo
20 Recruiting Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
Condition: Hepatitis B
Interventions: Drug: Entecavir;   Drug: Entecavir, Adefovir

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years